Patents by Inventor Evangelos J. Giamarellos-Bourboulis

Evangelos J. Giamarellos-Bourboulis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF HIDRADENITIS SUPPURATIVA
    Publication number: 20240025989
    Abstract: Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1?.
    Type: Application
    Filed: September 29, 2023
    Publication date: January 25, 2024
    Inventors: Evangelos J. GIAMARELLOS-BOURBOULIS, Stanley A. Kim
  • TREATMENT OF HIDRADENITIS SUPPURATIVA
    Publication number: 20220127353
    Abstract: Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1?.
    Type: Application
    Filed: January 6, 2022
    Publication date: April 28, 2022
    Inventors: Evangelos J. GIAMARELLOS-BOURBOULIS, Stanley A. KIM
  • Treatment of hidradenitis suppurativa
    Patent number: 11225517
    Abstract: Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1?.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: January 18, 2022
    Assignee: Janssen Biotech, Inc.
    Inventors: Evangelos J. Giamarellos-Bourboulis, Stanley A. Kim
  • TREATMENT OF HIDRADENITIS SUPPURATIVA
    Publication number: 20210179704
    Abstract: Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1?.
    Type: Application
    Filed: November 24, 2020
    Publication date: June 17, 2021
    Inventors: Evangelos J. GIAMARELLOS-BOURBOULIS, Stanley A. KIM
  • TREATMENT OF HIDRADENITIS SUPPURATIVA
    Publication number: 20200277370
    Abstract: Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1?.
    Type: Application
    Filed: February 27, 2020
    Publication date: September 3, 2020
    Inventors: Evangelos J. GIAMARELLOS-BOURBOULIS, Stanley A. KIM
  • TREATMENT OF HIDRADENITIS SUPPURATIVA
    Publication number: 20190389946
    Abstract: Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1?.
    Type: Application
    Filed: August 14, 2019
    Publication date: December 26, 2019
    Inventors: Evangelos J. Giamarellos-Bourboulis, Stanley A. Kim
  • TREATMENT OF HIDRADENITIS SUPPURATIVA
    Publication number: 20180230211
    Abstract: Hidradenitis suppurativa can be treated by administering a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1?.
    Type: Application
    Filed: February 20, 2018
    Publication date: August 16, 2018
    Inventors: Evangelos J. Giamarellos-Bourboulis, Stanley A. Kim